ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome
ClinicoEconomics and Outcomes Research
◽
10.2147/ceor.s317390
◽
2021
◽
Vol Volume 13
◽
pp. 703-715
Author(s):
Sermsiri Sangroongruangsri
◽
Kankamon Kittrongsiri
◽
Phunchai Charatcharoenwitthaya
◽
Abhasnee Sobhonslidsuk
◽
Usa Chaikledkaew
Keyword(s):
Hepatorenal Syndrome
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Type 1 Hepatorenal Syndrome
Download Full-text
Related Documents
Cited By
References
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis
Value in Health
◽
10.1016/j.jval.2017.05.021
◽
2017
◽
Vol 20
(10)
◽
pp. 1279-1287
◽
Cited By ~ 4
Author(s):
Dalia Dawoud
◽
Elisabetta Fenu
◽
Bernard Higgins
◽
David Wonderling
◽
Stephanie A. Amiel
Keyword(s):
Diabetes Mellitus
◽
Type 1 Diabetes
◽
Type 1 Diabetes Mellitus
◽
Basal Insulin
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
Download Full-text
PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL
Value in Health
◽
10.1016/j.jval.2020.04.217
◽
2020
◽
Vol 23
◽
pp. S113
Author(s):
R. Pollock
◽
W.J. Valentine
Keyword(s):
Type 1 Diabetes
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Sodium Glucose Cotransporter
◽
Diabetes Model
◽
The Usa
◽
Bolus Insulin
◽
Basal Bolus
Download Full-text
ND2 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT
Value in Health
◽
10.1016/j.jval.2019.04.060
◽
2019
◽
Vol 22
◽
pp. S42-S43
◽
Cited By ~ 1
Author(s):
D. Malone
◽
R. Dean
◽
B. Miller
◽
R. Arjunji
◽
D.E. Feltner
◽
...
Keyword(s):
Single Dose
◽
Spinal Muscular Atrophy
◽
Muscular Atrophy
◽
Gene Replacement
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Spinal Muscular Atrophy Type
◽
Gene Replacement Therapy
Download Full-text
Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia
Value in Health
◽
10.1016/j.jval.2015.09.693
◽
2015
◽
Vol 18
(7)
◽
pp. A360
Author(s):
H Quitian
◽
AM Gomez
◽
AA Garcia Peña
◽
J Arciniegas
◽
N Iragorri
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 1 Diabetes
◽
Infusion Pump
◽
Cost Utility
◽
Cost Utility Analysis
◽
Daily Injection
◽
Utility Analysis
◽
Integrated Monitoring
◽
Multiple Daily Injection
Download Full-text
Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia
Value in Health
◽
10.1016/j.jval.2016.09.1885
◽
2016
◽
Vol 19
(7)
◽
pp. A674-A675
Author(s):
M Culic
◽
M Russel-Szymczyk
◽
B Chubb
◽
C Tikkanen
Keyword(s):
Diabetes Mellitus
◽
Insulin Glargine
◽
Diabetes Mellitus Type 1
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Diabetes Mellitus Type
◽
Utility Analysis
◽
Patients With Diabetes
Download Full-text
PDB21 A COST-UTILITY ANALYSIS OF INSULIN GLARGINE (LANTUS®) IN THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES
Value in Health
◽
10.1016/s1098-3015(10)61744-5
◽
2003
◽
Vol 6
(6)
◽
pp. 682
Author(s):
FK Kristensen
◽
JM Sverre
◽
S Bustad
Keyword(s):
Type 1 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
Download Full-text
PMD41 Insulin Pump Cost-Utility Analysis Compared to Multiple Daily Injection in Type 1 Diabetic Patients in the Mexican Social Security Institute, 21St Century Hospital
Value in Health
◽
10.1016/j.jval.2012.03.381
◽
2012
◽
Vol 15
(4)
◽
pp. A69
Author(s):
M. Quiroz
◽
F. Machado
◽
J. Shafiroff
◽
M. Gill
◽
M. Molina
◽
...
Keyword(s):
Insulin Pump
◽
Cost Utility
◽
Cost Utility Analysis
◽
Daily Injection
◽
Diabetic Patients
◽
Utility Analysis
◽
Multiple Daily Injection
◽
Type 1 Diabetic Patients
◽
Social Security Institute
Download Full-text
A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark
Journal of Medical Economics
◽
10.1080/13696998.2016.1245663
◽
2016
◽
Vol 20
(3)
◽
pp. 213-220
◽
Cited By ~ 8
Author(s):
R. F. Pollock
◽
C. K. Tikkanen
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Utility Analysis
◽
Short Term
Download Full-text
Basal Insulin Regimens: Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults
Value in Health
◽
10.1016/j.jval.2015.09.136
◽
2015
◽
Vol 18
(7)
◽
pp. A339
◽
Cited By ~ 1
Author(s):
D Dawoud
◽
E Fenu
◽
D Wonderling
◽
R O’Mahony
◽
N Pursey
◽
...
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 1 Diabetes
◽
Clinical Guideline
◽
Meta Analysis
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Nice Clinical Guideline
Download Full-text
PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN
Value in Health
◽
10.1016/j.jval.2020.04.810
◽
2020
◽
Vol 23
◽
pp. S239
Author(s):
R. Dean
◽
B. Miller
◽
R. Arjunji
◽
H. Awano
◽
A. Igarashi
◽
...
Keyword(s):
Single Dose
◽
Spinal Muscular Atrophy
◽
Muscular Atrophy
◽
Gene Replacement
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Spinal Muscular Atrophy Type
◽
Gene Replacement Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close